Suppr超能文献

使用循环死亡后捐赠器官进行肝移植的结果:单中心经验

Outcomes of liver transplantations using donations after circulatory death: a single-center experience.

作者信息

Meurisse N, Vanden Bussche S, Jochmans I, Francois J, Desschans B, Laleman W, Van der Merwe S, Van Steenbergen W, Cassiman D, Verslype C, Aerts R, Nevens F, Pirenne J, Monbaliu D

机构信息

Leuven Liver Transplant Team, University Hospitals Leuven, Leuven, Belgium.

出版信息

Transplant Proc. 2012 Nov;44(9):2868-73. doi: 10.1016/j.transproceed.2012.09.077.

Abstract

INTRODUCTION

Orthotopic liver transplantation (OLT) (LTx) using donation after circulatory death (DCD) donors is increasingly performed, but still considered to risk of poorer outcomes compared with standard donations after brain death (DBD)-OLT. Therefore we reviewed our results of DCD-OLT.

PATIENTS AND METHODS

Between 2003 and 2010, we performed 30 DCD-OLT (6% of all OLT). We retrospectively reviewed medical records of donors and recipients after DCD versus DBD-OLT to analyze biliary complications, retransplantation rates, and patient/graft survivals.

RESULTS

Median donor age was similar for DCD and DBD-OLT: 51 versus 53 years (P = .244). Median donor warm ischemia time (stop ventilation to cold perfusion in DCD donors) was 24 minutes. Median cold ischemia time was shorter for DCD (6 hours 54 minutes) compared with DBD-OLT (8 hours 36 minutes; P < .0001). Median laboratory model of end-stage liver disease score was 15 for DCD, and 16 for DBD-OLT (P = .59). Median post-OLT Aspartate Aminotransferase (AST) peak was higher after DCD: 1178 versus DBD-OLT 651 IU/L (P = .005). The incidence of nonanastomotic strictures was different: 33.3% for DCD versus 12.5% for DBD-OLT (P = .001). The overall retransplantation rate was 3% after both DCD and DBD-OLT. After DCD-LTx actuarial 1, 3- and 5-year patient survivals were 93, 85 and 85%, and corresponding graft survivals, 90%, 82%, and 82% respectively, and not different compared with DBD-OLT: 88%, 78%, and 72% (P = .348) and 85%, 74%, and 68% (P = .524) respectively.

CONCLUSION

Despite substantial ischemic injury (high peak AST and biliary strictures) short- and long-term survival after DCD-OLT was comparable to DBD-OLT. Rapid donor surgery, careful donor and recipient selection, as well as short warm and cold ischemia times are key factors to optimize outcomes after DCD-OLT. However, strategies to reduce biliary complications remain warranted.

摘要

引言

使用心脏死亡后捐赠(DCD)供体的原位肝移植(OLT)(肝移植)越来越普遍,但与标准脑死亡后捐赠(DBD)-OLT相比,其结果仍被认为有较差预后的风险。因此,我们回顾了我们的DCD-OLT结果。

患者与方法

2003年至2010年期间,我们进行了30例DCD-OLT(占所有OLT的6%)。我们回顾性分析了DCD与DBD-OLT后供体和受体的病历,以分析胆道并发症、再次移植率以及患者/移植物存活率。

结果

DCD和DBD-OLT的供体年龄中位数相似:分别为51岁和53岁(P = 0.244)。DCD供体的供体热缺血时间(从停止通气到冷灌注)中位数为24分钟。DCD的冷缺血时间中位数(6小时54分钟)短于DBD-OLT(8小时36分钟;P < 0.0001)。DCD的终末期肝病实验室模型评分中位数为15,DBD-OLT为16(P = 0.59)。DCD后OLT天门冬氨酸氨基转移酶(AST)峰值中位数较高:1178 IU/L,而DBD-OLT为651 IU/L(P = 0.005)。非吻合口狭窄的发生率不同:DCD为33.3%,DBD-OLT为12.5%(P = 0.001)。DCD和DBD-OLT后的总体再次移植率均为3%。DCD肝移植后1年、3年和5年的患者生存率分别为93%、85%和85%,相应的移植物存活率分别为90%、82%和82%,与DBD-OLT相比无差异:分别为88%、78%和72%(P = 0.348)以及85%、74%和68%(P = 0.524)。

结论

尽管存在严重的缺血性损伤(AST峰值高和胆道狭窄),DCD-OLT后的短期和长期生存率与DBD-OLT相当。快速的供体手术、仔细的供体和受体选择以及较短的热缺血和冷缺血时间是优化DCD-OLT后结果的关键因素。然而,减少胆道并发症的策略仍然是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验